Showing results (1-10 of 20) with videos related to
Sort By:
Pageof 2
Discovery Medicine|March 2, 2011
The role of the epidermal growth factor receptor in the mechanism and treatment of colorectal cancerNirit Yarom, Derek J JonkerHarefuah|February 3, 2006
[Taxotere-based chemotherapy in androgen-independent prostate cancer]Nirit Yarom, Svetlana Kovel, Avishay SellaHarefuah|January 25, 2022
[GERIATRIC ONCOLOGY - CANCER TREATMENT IN OLDER ADULTS AND OLDEST-OLD]Raya Leibowitz, Galina Plotnikov, Nirit Yarom, et al.Clinical Colorectal Cancer|September 25, 2019
KRAS Status as a Predictor of Chemotherapy Activity in Patients With Metastatic Colorectal CancerNirit Yarom, Gillian Gresham, Nana Boame, et al.BJU International|June 15, 2007
Progression after docetaxel-based chemotherapy in androgen-independent prostate cancerAvishay Sella, Cora Sternberg, Svetlana Kovel, et al.Basic & Clinical Pharmacology & Toxicology|February 5, 2009
Epistaxis during treatment with paclitaxelNirit Yarom, Arnoldo Cyjon, Svetlana Kovel, et al.Urology|March 1, 2008
Neoadjuvant chemohormonal therapy in poor-prognosis localized prostate cancerAvishay Sella, Amnon Zisman, Svetlana Kovel, et al.Current Clinical Pharmacology|January 28, 2012
Phase I clinical trial of Exherin (ADH-1) in patients with advanced solid tumorsNirit Yarom, David Stewart, Rajesh Malik, et al.Anticancer Research|November 24, 2011
ADH-1 in the treatment of metastatic adrenocortical carcinoma--case reportNirit Yarom, David Stewart, Leonard Avruch, et al.The Israel Medical Association Journal : IMAJ|February 23, 2016
D1 versus D2 Gastrectomy for Gastric AdenocarcinomaRon Lavy, Yehuda Hershkovitz, Bar Chikman, et al.Pageof 2